Hilde H. Nordal
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Calprotectin (S100A8/A9) is not associated with ultrasound-detected synovitis in a longitudinal study of patients with psoriatic arthritis treated with biological disease-modifying anti-rheumatic drugs.
Journal: Scandinavian journal of rheumatology
Published: August 13, 2025
Prevalence of spondyloarthritis in inflammatory bowel disease according ASAS and ultrassonography and its correlation with plasma calprotectin.
Journal: Advances in rheumatology (London, England)
Published: September 28, 2023
Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis.
Journal: Scandinavian journal of clinical and laboratory investigation
Published: December 28, 2017
Response to: 'Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis' by Chevreau et al.
Journal: Annals of the rheumatic diseases
Published: December 22, 2017
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: April 26, 2017
Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis.
Journal: Arthritis research & therapy
Published: October 06, 2016
Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab.
Journal: Scandinavian journal of rheumatology
Published: January 16, 2016
Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome.
Journal: Clinical and experimental rheumatology
Published: December 05, 2015
Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab Treatment.
Journal: International journal of rheumatology
Published: September 18, 2015
The neutrophil protein S100A12 is associated with a comprehensive ultrasonographic synovitis score in a longitudinal study of patients with rheumatoid arthritis treated with adalimumab.
Journal: BMC musculoskeletal disorders
Published: July 08, 2014
Calprotectin (S100A8/A9), S100A12, and EDTA-resistant S100A12 complexes (ERAC) in primary Sjögren's syndrome.
Journal: Scandinavian journal of rheumatology
Published: December 04, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026